Artielle ImmunoTherapeutics Company

Artielle ImmunoTherapeutics develops recombinant T-cell receptor ligands to treat T-cell-mediated inflammatory diseases.
Technology: Cell-based gene therapy, Medical Devices
Industry: PharmTech, Private
Headquarters: San Mateo, California, United States
Zip: 1-10
Founded Date: 2004-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Acquisitions Number: 4
Investors Number: 4
Total Funding: 11185740
Estimated Revenue: $1M to $10M
Last Funding Date: 2010-04-13
Last Funding Type: Convertible Note

Visit Website
info@artielle.com
https://www.crunchbase.com/organization/artielle-immunotherapeutics
Register and Claim Ownership